Health-care leaders are expressing concern over how the Trump administration plans to distribute the promising coronavirus drug remdesivir, saying they are in the dark about the allocation criteria being used and are worried it isn’t based on need.
Some hospital officials say they have been informed they can’t get the drug since the federal government took over its allocation following the Food and Drug Administration’s emergency use authorization on May 1.
…
